Actively Recruiting
Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
Led by Fondazione G.B. Bietti, IRCCS · Updated on 2025-02-27
16
Participants Needed
2
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.
CONDITIONS
Official Title
Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness
You will not qualify if you...
- Age under 18 years
- Unable to read, understand, and sign the written informed consent
- Unable to perform visual field test
- Advanced glaucoma with cup-to-disc ratio greater than 0.7
- Other causes of optic neuropathies
- Retinal or macular diseases
- Lens or corneal opacities
- Spherical refractive defect greater than 7 diopters
- Cylindric refractive defect greater than 3 diopters
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
IRCCS-Fondazione GB Bietti
Rome, Italy
Actively Recruiting
2
University of Rome Tor Vergata
Rome, Italy
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here